News
-
-
PRESS RELEASE
Eleventh acquisition in 2024: Mutares has successfully completed the acquisition of Wilda Transport och Entreprenad AB and NU Entreprenad AB from Wilton Invest AB
Mutares SE & Co. KGaA completes the acquisition of Wilda Transport och Entreprenad AB and NU Entreprenad AB from Wilton Invest AB, strengthening Terranor AB with EUR 10 million revenues in 2023 -
-
-
-
-
-
REGULATED PRESS RELEASE
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA -
-